AbbVie sues HHS over 340B patient definition

Ella Jeffries / beckershospitalreview - AbbVie has filed a lawsuit challenging federal guidance on how “patient” is defined under the 340B program, according to an April 8 press release. The company said the current definition, based on guidance issued in 1996, allows covered entities to claim …

AI Summary: AbbVie has filed suit challenging HHS’s interpretation of the 340B program, arguing the agency’s “patient” definition and related guidance are outdated and legally flawed. The company seeks judicial clarity that could reshape who qualifies for discounted drugs and how hospitals and manufacturers navigate the program — yes, the pricing drama continues.

#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy #hospitaloperations #healthcarefinance #pricetransparency

4 months / fiercehealthcare


Back to Top / Thu, April 9, 2026, 2:23 pm / permalink 21967 / 4 stories in 4 months /




Related Stories


340B discounts face reform as profits outpace patient benefit / 4 months

Congress moves to curb HHS' 340B rebate pilot with bill / 22 days

Thousands of Medicare beneficiaries unexpectedly lose 'free' drug plans / 7 wks

Bill would let patient drug spending count toward insurance deductibles / 4 months

Tampa General sues Eli Lilly over pulled 340B discounts / 7 wks

CMS ends Medicare Part D premium subsidy for drug plans / 4 wks

D.C. appeals court upholds HHS control in 340B rebate dispute / 5 wks

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Adolescent Health, Pharmaceuticals, Venture Capital, Drug Development and look for the RSS link.





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.